Shots: CytoDyn is collaborating with the UK’s Department of Health to provide emergency access to its investigational therapy, leronlimab to treat patients with COVID-19. The MHRA’s submission is expected to be made soon to include clinical sites in the UK The US FDA has approved the initiation of its P-IIb/III clinical study for severe and […]Read More
